Cynthia Sirard
Förmögenhet: 31 075 $ per 2026-05-31
Förmögenhet: 31 075 $ per 2026-05-31
Cynthia Sirard is Chief Medical Officer at Compass Therapeutics, Inc. since 2026.
Formerly, Dr. Sirard was Chief Medical Officer at Cypherpunk Technologies, Inc. from 2020 to 2025 and Medical Director at PAREXEL International Corp.
from 2003 to 2005.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Chicago Medical School.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-20 | 27 500 ( 0,03 % ) | 31 075 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2026-01-01 |
| Företag | Position | Slut |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-07-31 |
| PAREXEL INTERNATIONAL CORPORATION | Företagsledare/Principal | 2005-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån